Shanghai Industrial Holdings (363) H2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2025 earnings summary
2 Sep, 2026Executive summary
Revenue for 2025 was HK$20,832 million, down 28% year-over-year, mainly due to lower property sales and construction revenue in the real estate and environmental segments.
Net profit decreased 28.1% year-over-year to HK$2,020 million, with EPS at HK$1.858 compared to HK$2.582 last year.
The Board recommended a final dividend of HK50 cents per share, a special dividend of HK20 cents, and an interim dividend of HK42 cents, totaling HK112 cents per share for 2025.
Financial highlights
Gross profit margin increased by 2.5 percentage points year-over-year, driven by a higher proportion of consumer products revenue.
Infrastructure and environmental protection contributed HK$1,801 million in net profit, down 31.5% year-over-year, accounting for 93.4% of Net Business Profit.
Real estate recorded a net loss of HK$632 million, with increased impairment provisions and lower property sales.
Consumer products net profit rose 17.5% to HK$756 million, with Nanyang Tobacco sales up 12.6% year-over-year.
Comprehensive healthcare operations net profit dropped 95.7% to HK$2.34 million after disposal of a major associate.
Outlook and guidance
Management expects a complex global economic landscape in 2026, with China focusing on boosting domestic demand and green transformation.
Infrastructure and environmental protection will leverage favorable policies to expand market share and project portfolio.
Real estate market remains uncertain, but policies are expected to remain accommodative, focusing on prime cities and quality homes.
Consumer products will prioritize innovation, digital transformation, and efficiency to drive growth.
Latest events from Shanghai Industrial Holdings
- Revenue and profit declined year-over-year, but consumer products delivered robust growth.363
H1 2024 - Revenue and profit declined, but infrastructure and consumer products showed strong growth.363
H2 2024 - Profit and revenue declined due to real estate losses, but consumer and healthcare segments grew strongly.363
H1 2025 - Net profit rose 1.6% to HK$1,058 million despite a 7.1% revenue decline, with improved margins.363
H1 2026